Mains Ready By December. Smash Mains & Smash PYQ Admissions Open
Talk to Mentor
Skip to content
Civilsdaily
Category:
Ranker Webinars
भारत में हरित क्रांति
[November Batch For UPSC 2025 & 2026] Our UAP Mentorship Student Got AIR 2, Animesh Pradhan, First Attempt, Working Professional. Join UAP 2025 & 2026.
[UPSC Openhouse] By Pravin Garje, Senior UPSC Mentor || Clear UPSC with Structured Mentorship | Learn How AIR 2, 22, and 48 Used One-on-One Mentorship | Join on 17th Oct, at 7:00 PM
UPSC पद और वेतन सूची
[UPSC Openhouse] By Shashwat Agrawal, IPS 2024 | Are 8 Months Enough to Crack UPSC CSE? | Get an 8-Month Blueprint for UPSC 2025 || Join on 13th Oct 2024 at 7:00 PM
UPSC CSE Mains GS4 Microthemes Analysis
UPSC CSE Mains GS3 Microthemes Analysis
UPSC CSE Mains GS2 Microthemes Analysis
UPSC CSE Mains GS1 Microthemes Analysis
Dr. Srinivasan is a senior scientist working for a reputed biotechnology company known for its cutting-edge research in pharmaceuticals. Dr. Srinivasan is heading a research team working on a new drug aimed at treating a rapidly spreading variant of a new viral infectious disease. The disease has been rapidly spreading across the world and the cases reported in the country are increasing. There is huge pressure on Dr. Srinivasan’s team to expedite the trials for the drug as there is significant market for it, and the company wants to get the first-mover advantage in the market. During a team meeting, some senior team members suggest some shortcut for expediting the clinical trials for the drug and for getting the requisite approvals. These include manipulating data to exclude some negative outcomes and selectively reporting positive results, foregoing the process of informed consent and using compounds already patented by a rival company, rather than developing one’s own component. Dr. Srinivasan is not comfortable taking such shortcuts, at the same time he realises meeting the targets is impossible without using these means